Hubei Guangji Pharmaceutical (000952.SZ) has had its application for issuing stocks to specific objects in 2026 accepted by the Shenzhen Stock Exchange.

11:58 27/08/2026

Guangji Pharmaceutical (000952.SZ) announced that on August 26, 2026, it received a notification from the Shenzhen Stock Exchange regarding the acceptance of the application documents for the issuance of shares to specific targets by Hubei Guangji Pharmaceutical Co., Ltd. (Shenzhen Stock Exchange Review [2026] No. 272). The Shenzhen Stock Exchange has verified the application documents submitted by the company for the issuance of shares to specific targets, found that the documents are complete, and decided to accept the application.

Hubei Guangji Pharmaceutical (000952.SZ) announced that on August 26, 2026, it received a notice from the Shenzhen Stock Exchange regarding the acceptance of the application documents for the issuance of shares to specific targets (Shenzhen Stock Exchange Review [2026] No. 272). The Shenzhen Stock Exchange verified the application documents submitted by the company for the issuance of shares to specific targets, deemed the application documents complete, and decided to accept the application.

MIXUE GROUP (02097) achieved revenue of approximately 15.216 billion yuan in the first half of the year, a year-on-year increase of 2.3%. The global store network continues to expand.

JINHUI HOLDINGS (00137): Jinhui Shipping's comprehensive net profit for the first half of the year is $9.593 million, a decrease of 36.68% year-on-year.

Morgan Stanley, UBS, and other institutions are optimistic about Kuaishou (01024) regarding growth in AI and gaming: model upgrades and new game performances serve as potential catalysts.

MIXUE GROUP (02097) achieved revenue of approximately 15.216 billion yuan in the first half of the year, a year-on-year increase of 2.3%. The global store network continues to expand.

JINHUI HOLDINGS (00137): Jinhui Shipping's comprehensive net profit for the first half of the year is $9.593 million, a decrease of 36.68% year-on-year.

Morgan Stanley, UBS, and other institutions are optimistic about Kuaishou (01024) regarding growth in AI and gaming: model upgrades and new game performances serve as potential catalysts.